Extracellular Matrix–Bound Angiopoietin-Like 4 Inhibits Endothelial Cell Adhesion, Migration, and Sprouting and Alters Actin Cytoskeleton

Angiopoietin-like 4 (ANGPTL4) is a secreted protein that belongs to the angiopoietin family and is involved in angiogenesis and metabolism regulation. We previously reported the induction of angptl4 by hypoxia in endothelial cells and in human ischemic tissues from peripheral artery disease. We here observed in a mouse model of hindlimb ischemia that the mRNA upregulation in the vessels correlates with the accumulation of the full-length protein in ischemic tissues. We then investigated its functions in endothelial cells. In response to hypoxia, endogenous ANGPTL4 accumulates in the subendothelial extracellular matrix (ECM). Although the secreted protein undergoes proteolysis leading to truncated fragments present in the medium, only full-length ANGPTL4 interacts with the ECM. Competition and direct binding assays indicate that the strong interaction of ANGPTL4 with the ECM is heparin/heparan sulfate proteoglycan dependent. The balance between matrix-associated and soluble forms of ANGPTL4 points to the role of the ECM in the regulation of its bioavailability. The angiogenic function of the ECM-bound full-length protein was investigated using either the form associated with the conditioned ECM from ANGPTL4-transfected HEK293 cells or the purified immobilized protein. We show that matrix-associated and immobilized ANGPTL4 limit the formation of actin stress fibers and focal contacts in the adhering endothelial cells and inhibit their adhesion. Immobilized ANGPTL4 also decreases motility of endothelial cells and inhibits the sprouting and tube formation. Altogether, these findings show that hypoxic endothelial cells accumulate ANGPTL4 in the ECM, which in turn negatively regulates their angiogenic capacities through an autocrine pathway.

[1]  J. Isner,et al.  Mouse model of angiogenesis. , 1998, The American journal of pathology.

[2]  Kenichi Yoshida,et al.  Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase Published, JLR Papers in Press, September 16, 2002. DOI 10.1194/jlr.C200010-JLR200 , 2002, Journal of Lipid Research.

[3]  Pierre Corvol,et al.  Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. , 2003, The American journal of pathology.

[4]  Kenichi Yoshida,et al.  Protein Region Important for Regulation of Lipid Metabolism in Angiopoietin-like 3 (ANGPTL3) , 2003, Journal of Biological Chemistry.

[5]  Meijia Yang,et al.  Angioarrestin: an antiangiogenic protein with tumor-inhibiting properties. , 2002, Cancer research.

[6]  W. Wahli,et al.  The Direct Peroxisome Proliferator-activated Receptor Target Fasting-induced Adipose Factor (FIAF/PGAR/ANGPTL4) Is Present in Blood Plasma as a Truncated Protein That Is Increased by Fenofibrate Treatment* , 2004, Journal of Biological Chemistry.

[7]  Nolwenn Le Meur,et al.  Characterization of the expression of the hypoxia‐induced genes neuritin, TXNIP and IGFBP3 in cancer , 2006, FEBS letters.

[8]  G. Camenisch,et al.  ANGPTL3 Stimulates Endothelial Cell Adhesion and Migration via Integrin αvβ3 and Induces Blood Vessel Formation in Vivo * , 2002, The Journal of Biological Chemistry.

[9]  T. V. Kolesnikova,et al.  Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. , 1997, Experimental cell research.

[10]  Qin Yu,et al.  Angiopoietin-1, Unlike Angiopoietin-2, Is Incorporated into the Extracellular Matrix via Its Linker Peptide Region* , 2001, The Journal of Biological Chemistry.

[11]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[12]  P. Carmeliet Angiogenesis in health and disease , 2003, Nature Medicine.

[13]  J. Murphy-Ullrich The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? , 2001, The Journal of clinical investigation.

[14]  H. Augustin,et al.  Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. , 1999, Journal of cell science.

[15]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[16]  P. Bornstein,et al.  Matricellular proteins: extracellular modulators of cell function. , 2002, Current opinion in cell biology.

[17]  G. Davis,et al.  This Review Is Part of a Thematic Series on Vascular Cell Diversity, Which Includes the following Articles: Heart Valve Development: Endothelial Cell Signaling and Differentiation Molecular Determinants of Vascular Smooth Muscle Cell Diversity Endothelial/pericyte Interactions Endothelial Extracellu , 2022 .

[18]  Guoqing Yang,et al.  Oligomerization and Regulated Proteolytic Processing of Angiopoietin-like Protein 4* , 2004, Journal of Biological Chemistry.

[19]  Kok Weng Chan,et al.  Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  G. Koh,et al.  Molecular Cloning, Expression, and Characterization of Angiopoietin-related Protein , 1999, The Journal of Biological Chemistry.

[21]  Seng H. Cheng,et al.  Hypoxia up-regulates expression of peroxisome proliferator-activated receptor gamma angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor 1alpha. , 2002, Journal of molecular and cellular cardiology.

[22]  M. Mrksich,et al.  Direct Cell Adhesion to the Angiopoietins Mediated by Integrins* , 2001, The Journal of Biological Chemistry.

[23]  Seng H. Cheng,et al.  Hypoxia Up-regulates Expression of Peroxisome Proliferator-activated Receptor γ Angiopoietin-related Gene (PGAR) in Cardiomyocytes: Role of Hypoxia Inducible Factor 1α , 2002 .

[24]  G. Camenisch,et al.  ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. , 2002, The Journal of biological chemistry.

[25]  B. Spiegelman,et al.  Peroxisome Proliferator-Activated Receptor γ Target Gene Encoding a Novel Angiopoietin-Related Protein Associated with Adipose Differentiation , 2000, Molecular and Cellular Biology.

[26]  A. Schwartz,et al.  Interactions between tissue-type plasminogen activator and extracellular matrix-associated plasminogen activator inhibitor type 1 in the human hepatoma cell line HepG2. , 1989, The Journal of biological chemistry.

[27]  H. G. Kim,et al.  Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. , 2000, The Biochemical journal.

[28]  D. Brigstock The Connective Tissue Growth Factor/cysteine- Rich 61/nephroblastoma Overexpressed (ccn) Family* , 2022 .

[29]  Kenny K. Wong,et al.  Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Y. Masuho,et al.  Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4. , 2003, Cancer research.

[31]  T. Suda,et al.  Cooperative interaction of Angiopoietin-like proteins 1 and 2 in zebrafish vascular development. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Witte,et al.  Angiopoietin-like-4 is a potential angiogenic mediator in arthritis. , 2005, Clinical immunology.

[33]  P. Chambon,et al.  Characterization of the Fasting-induced Adipose Factor FIAF, a Novel Peroxisome Proliferator-activated Receptor Target Gene* , 2000, The Journal of Biological Chemistry.

[34]  N. Ortéga,et al.  Extracellular matrix‐bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.